| Designer vaccine nanodiscs for personalized cancer immunotherapy R Kuai, LJ Ochyl, KS Bahjat, A Schwendeman, JJ Moon Nature materials 16 (4), 489-496, 2017 | 918 | 2017 |
| Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets YN Naumov, KS Bahjat, R Gausling, R Abraham, MA Exley, Y Koezuka, ... Proceedings of the National Academy of Sciences 98 (24), 13838-13843, 2001 | 391 | 2001 |
| Listeria-based cancer vaccines that segregate immunogenicity from toxicity DG Brockstedt, MA Giedlin, ML Leong, KS Bahjat, Y Gao, W Luckett, ... Proceedings of the National Academy of Sciences 101 (38), 13832-13837, 2004 | 352 | 2004 |
| Optimizing timing of immunotherapy improves control of tumors by hypofractionated radiation therapy KH Young, JR Baird, T Savage, B Cottam, D Friedman, S Bambina, ... PloS one 11 (6), e0157164, 2016 | 303 | 2016 |
| Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria NW Schmidt, RL Podyminogin, NS Butler, VP Badovinac, BJ Tucker, ... Proceedings of the National Academy of Sciences 105 (37), 14017-14022, 2008 | 301 | 2008 |
| VISTA is an acidic pH-selective ligand for PSGL-1 RJ Johnston, LJ Su, J Pinckney, D Critton, E Boyer, A Krishnakumar, ... Nature 574 (7779), 565-570, 2019 | 264 | 2019 |
| Radiotherapy combined with novel STING-targeting oligonucleotides results in regression of established tumors JR Baird, D Friedman, B Cottam, TW Dubensky Jr, DB Kanne, S Bambina, ... Cancer research 76 (1), 50-61, 2016 | 226 | 2016 |
| Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25 D Hannani, M Vétizou, D Enot, S Rusakiewicz, N Chaput, D Klatzmann, ... Cell research 25 (2), 208-224, 2015 | 183 | 2015 |
| NK cell–mediated killing of target cells triggers robust antigen-specific T cell–mediated and humoral responses P Krebs, MJ Barnes, K Lampe, K Whitley, KS Bahjat, B Beutler, E Janssen, ... Blood, The Journal of the American Society of Hematology 113 (26), 6593-6602, 2009 | 181 | 2009 |
| Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity DG Brockstedt, KS Bahjat, MA Giedlin, W Liu, M Leong, W Luckett, Y Gao, ... Nature medicine 11 (8), 853-860, 2005 | 170 | 2005 |
| CD8+ T cell priming by dendritic cell vaccines requires antigen transfer to endogenous antigen presenting cells AW Yewdall, SB Drutman, F Jinwala, KS Bahjat, N Bhardwaj PloS one 5 (6), e11144, 2010 | 149 | 2010 |
| Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway E Janssen, K Tabeta, MJ Barnes, S Rutschmann, S McBride, KS Bahjat, ... Immunity 24 (6), 787-799, 2006 | 114 | 2006 |
| A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic … T Crocenzi, B Cottam, P Newell, RF Wolf, PD Hansen, C Hammill, ... Journal for immunotherapy of cancer 4, 1-13, 2016 | 103 | 2016 |
| Increased survival in sepsis by in vivo adenovirus-induced expression of IL-10 in dendritic cells A Oberholzer, C Oberholzer, KS Bahjat, R Ungaro, CL Tannahill, ... The Journal of Immunology 168 (7), 3412-3418, 2002 | 94 | 2002 |
| Cytosolic Entry Controls CD8+-T-Cell Potency during Bacterial Infection KS Bahjat, W Liu, EE Lemmens, SP Schoenberger, DA Portnoy, ... Infection and immunity 74 (11), 6387-6397, 2006 | 91 | 2006 |
| Autoregulation of human monocyte-derived dendritic cell maturation and IL-12 production by cyclooxygenase-2-mediated prostanoid production DS Whittaker, KS Bahjat, LL Moldawer, MJ Clare-Salzler The Journal of Immunology 165 (8), 4298-4304, 2000 | 80 | 2000 |
| Isatuximab acts through Fc-dependent, independent, and direct pathways to kill multiple myeloma cells C Zhu, Z Song, A Wang, S Srinivasan, G Yang, R Greco, J Theilhaber, ... Frontiers in immunology 11, 1771, 2020 | 79 | 2020 |
| Constitutive activation of the PrfA regulon enhances the potency of vaccines based on live-attenuated and killed but metabolically active Listeria monocytogenes strains P Lauer, B Hanson, EE Lemmens, W Liu, WS Luckett, ML Leong, ... Infection and Immunity 76 (8), 3742-3753, 2008 | 74 | 2008 |
| INCREASED EXPRESSION OF THE LYMPHOCYTE EARLY ACTIVATION MARKER CD69 IN PERIPHERAL BLOOD CORRELATES WITH HISTOLOGIC EVIDENCE OF CARDIAC ALLOGRAFT REJECTION1 KO Schowengerdt, FJ Fricker, KS Bahjat, ST Kuntz Transplantation 69 (10), 2102-2107, 2000 | 70 | 2000 |
| Selective targeting of antitumor immune responses with engineered live-attenuated Listeria monocytogenes K Yoshimura, A Jain, HE Allen, LS Laird, CY Chia, S Ravi, DG Brockstedt, ... Cancer research 66 (2), 1096-1104, 2006 | 65 | 2006 |
Michael GoughEarle A. Chiles Research Institute, Providence Cancer Center, Portland ORBestätigte E-Mail-Adresse bei providence.org
